Vincere Biosciences

Vincere Biosciences is developing small molecule therapeutics to protect the body’s most mitochondria-dense organs including the brain, heart, and kidneys by enhancing the cell’s natural ability to clear out damaged mitochondria.Built at the intersection of AI-driven discovery and cutting-edge biology, Vincere targets a key driver of age-related decline: dysfunctional mitochondria. With programs advancing toward the clinic, the company is positioned to impact a range of diseases from Parkinson’s disease to cardiorenal conditions - and may more broadly extend healthy human lifespan.